TATE Versus TACE in Intermediate Stage HCC

Clinical trial NCT03145558 · TERMINATED

Trial details

NCT number: NCT03145558
Sponsor: Teclison Ltd.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Hepatocellular

Start date: 2017-12-05
Primary completion: 2024-06-30
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.